Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
H Lu, Q Zhou, J He, Z Jiang, C Peng, R Tong… - Signal transduction and …, 2020 - nature.com
Protein–protein interactions (PPIs) have pivotal roles in life processes. The studies showed
that aberrant PPIs are associated with various diseases, including cancer, infectious …
that aberrant PPIs are associated with various diseases, including cancer, infectious …
Targeting co-stimulatory molecules in autoimmune disease
NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …
Inhibition of CD40L with frexalimab in multiple sclerosis
P Vermersch, C Granziera… - … England Journal of …, 2024 - Mass Medical Soc
Abstract Background The CD40–CD40L costimulatory pathway regulates adaptive and
innate immune responses and has been implicated in the pathogenesis of multiple …
innate immune responses and has been implicated in the pathogenesis of multiple …
[HTML][HTML] Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
JL Karnell, SA Rieder, R Ettinger, R Kolbeck - Advanced drug delivery …, 2019 - Elsevier
CD40 is a TNF receptor superfamily member expressed on both immune and non-immune
cells. Interactions between B cell-expressed CD40 and its binding partner, CD40L …
cells. Interactions between B cell-expressed CD40 and its binding partner, CD40L …
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
Monocytes express various receptors, which monitor and sense environmental changes.
Monocytes are highly plastic and heterogeneous, and change their functional phenotype in …
Monocytes are highly plastic and heterogeneous, and change their functional phenotype in …
The safety and side effects of monoclonal antibodies
TT Hansel, H Kropshofer, T Singer, JA Mitchell… - Nature reviews Drug …, 2010 - nature.com
Monoclonal antibodies (mAbs) are now established as targeted therapies for malignancies,
transplant rejection, autoimmune and infectious diseases, as well as a range of new …
transplant rejection, autoimmune and infectious diseases, as well as a range of new …
Clinical targeting of the TNF and TNFR superfamilies
M Croft, CA Benedict, CF Ware - Nature reviews Drug discovery, 2013 - nature.com
Inhibitors of tumour necrosis factor (TNF) are among the most successful protein-based
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
drugs (biologics) and have proven to be clinically efficacious at reducing inflammation …
Autoimmune diseases
A Davidson, B Diamond - New England Journal of Medicine, 2001 - Mass Medical Soc
Autoimmune diseases, with the exception of rheumatoid arthritis and autoimmune thyroiditis,
are individually rare, but together they affect approximately 5 percent of the population in …
are individually rare, but together they affect approximately 5 percent of the population in …
Immunological and physiological observations in baboons with life‐supporting genetically engineered pig kidney grafts
H Iwase, H Hara, M Ezzelarab, T Li, Z Zhang… - …, 2017 - Wiley Online Library
Background Genetically engineered pigs could provide a source of kidneys for clinical
transplantation. The two longest kidney graft survivals reported to date have been 136 and …
transplantation. The two longest kidney graft survivals reported to date have been 136 and …
Heart transplantation in baboons using α1, 3-galactosyltransferase gene-knockout pigs as donors: initial experience
K Kuwaki, YL Tseng, FJMF Dor, A Shimizu… - Nature medicine, 2005 - nature.com
Abstract Hearts from α1, 3-galactosyltransferase knockout pigs (GalT-KO, n= 8) were
transplanted heterotopically into baboons using an anti-CD154 monoclonal antibody–based …
transplanted heterotopically into baboons using an anti-CD154 monoclonal antibody–based …